Therapeutic manipulation of gut microbiota by polysaccharides of Wolfiporia cocos reveals the contribution of the gut fungi-induced PGE₂ to alcoholic hepatic steatosis

References

• Cassard AM, Ciocan D. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol. 2018;24(2):100–13. doi:10.3350/cmh.2017.0067.
   PubMed Web of Science ®Google Scholar
• Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(4):235–246. doi:10.1038/s41575-018-0099-1.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol. 1994;89:2205–2211.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009;50(3):538–547. doi:10.1016/j.jhep.2008.10.028.
   PubMed Web of Science ®Google Scholar
• Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA, Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011;53(1):96–105. doi:10.1002/hep.24018.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B, Li L. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54(2):562–572. doi:10.1002/hep.24423.
   PubMed Web of Science ®Google Scholar
• Bjorkhaug ST, Aanes H, Neupane SP, Bramness JG, Malvik S, Henriksen C, Skar V, Medhus AW, Valeur J. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes. 2019;10(6):663–675. doi:10.1080/19490976.2019.1580097.
   PubMed Web of Science ®Google Scholar
• Xie GX, Zhong W, Zheng XJ, Li Q, Qiu YP, Li HK, Chen HY, Zhou ZX, Jia W. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J Proteome Res. 2013;12(7):3297–3306. doi:10.1021/pr400362z.
   PubMed Web of Science ®Google Scholar
• Brandl K, Hartmann P, Jih LJ, Pizzo DP, Argemi J, Ventura-Cots M, Coulter S, Liddle C, Ling L, Rossi SJ, et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J Heptol. 2018;69(2):396–405. doi:10.1016/j.jhep.2018.03.031.
   PubMed Web of Science ®Google Scholar
• Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127(7):2829–2841. doi:10.1172/JCI90562.
   PubMed Web of Science ®Google Scholar
• Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS, et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020;71(2):522–538. doi:10.1002/hep.30832.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F, Zhang LF, Faber F, Lopez CA, Byndloss MX, Olsan EE, Xu GG, Velazquez EM, Lebrilla CB, Winter SE, et al. Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella. Cell Host Microbe. 2016;19(4):443–454. doi:10.1016/j.chom.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Nunez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe. 2014;15(1):95–102. doi:10.1016/j.chom.2013.12.010.
   PubMed Web of Science ®Google Scholar
• Sun SS, Wang K, Ma K, Bao L, Liu HW. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota. Chin J Nat Med. 2019;17(1):3–14. doi:10.1016/S1875-5364(19)30003-2.
   PubMed Web of Science ®Google Scholar
• Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. 2011;54(6):2185–2197. doi:10.1002/hep.24599.
   PubMed Web of Science ®Google Scholar
• White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog. 2007;3(12):e184. doi:10.1371/journal.ppat.0030184.
   PubMed Web of Science ®Google Scholar
• Desai PR, van Wijlick L, Kurtz D, Juchimiuk M, Ernst JF. Hypoxia and temperature regulated morphogenesis in Candida albicans. PLoS Genet. 2015;11(8):e1005447. doi:10.1371/journal.
   PubMed Web of Science ®Google Scholar
• Vacca I. Microbiome: the microbiota maintains oxygen balance in the gut. Nat Rev Microbiol. 2017;15(10):574–575. doi:10.1038/nrmicro.2017.112.
   Web of Science ®Google Scholar
• Byndloss MX, Olsan EE, Rivera-Chavez F, Tiffany CR, Cevallos SA, Lokken KL, Torres TP, Byndloss AJ, Faber F, Gao YD, et al. Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357(6351):570–575. doi:10.1126/science.aam9949.
   PubMed Web of Science ®Google Scholar
• Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh AY. Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med. 2015;21(7):808–814. doi:10.1038/nm.3871.
   PubMed Web of Science ®Google Scholar
• Hamad I, Ranque S, Azhar EI, Yasir M, Jiman-Fatani AA, Tissot-Dupont H, Raoult D, Bittar F. Culturomics and amplicon-based metagenomic approaches for the study of fungal population in human gut microbiota. Sci Rep. 2017;7(1):16788. doi:10.1038/s41598-017-17132-4.
   PubMedGoogle Scholar
• Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Schemmer P, Bradford BU, Rivera CA, et al. Kupffer cell-derived prostaglandin E-2 is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol-Gastr L. 2000;279(1):G100–G106. doi:10.1152/ajpgi.2000.279.1.G100.
   PubMed Web of Science ®Google Scholar
• Dominguez M, Miquel R, Colmenero J, Moreno M, Garcia-Pagan JC, Bosch J, Arroyo V, Gines P, Caballeria J, Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136(5):1639–1650. doi:10.1053/j.gastro.2009.01.056.
   PubMed Web of Science ®Google Scholar
• Wang T, Fan C, Yao A, Xu X, Zheng G, You Y, Jiang C, Zhao X, Hou Y, Hung MC, et al. The adaptor protein CARD9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells. Immunity. 2018;49(3):504–514e4. doi:10.1016/j.immuni.2018.08.018.
   PubMed Web of Science ®Google Scholar
• Lemoinne S, Kemgang A, Ben Belkacem K, Straube M, Jegou S, Corpechot C, Saint-Antoine IBDN, Chazouilleres O, Housset C, Sokol H. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut. 2020;69(1):92–102. doi:10.1136/gutjnl-2018-317791.
   PubMed Web of Science ®Google Scholar
• Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, Chan FKL, Sung JJY, Yu J. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019;68(4):654–662. doi:10.1136/gutjnl-2018-317178.
   PubMed Web of Science ®Google Scholar
• Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, et al. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol. 2020;72(3):391–400. doi:10.1016/j.jhep.2019.09.029.
   PubMed Web of Science ®Google Scholar
• Henkel J, Coleman CD, Schraplau A, Johrens K, Weiss TS, Jonas W, Schurmann A, Puschel GP. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep. 2018;8(1):16127. doi:10.1038/s41598-018-34633-y.
   PubMed Web of Science ®Google Scholar
• Bjrnsson OG, Sparks JD, Sparks CE, Gibbons GF. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. J Lipid Res. 1992;33(7):1017–1027. doi:10.1016/0047-2484(92)90045-B.
   PubMed Web of Science ®Google Scholar
• Brass EP, Alford CE, Garrity MJ. Inhibition of glucagon-stimulated cAMP accumulation and fatty acid oxidation by E-series prostaglandins in isolated rat hepatocytes. Biochim Biophys Acta. 1987;930(1):122–126. doi:10.1016/0167-4889(87)90164-9.
   PubMedGoogle Scholar
• Mater MK, Thelen AP, Jump DB. Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression. J Lipid Res. 1999;40:1045.
   PubMed Web of Science ®Google Scholar
• Karck U, Peters T, Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol. 1988;7(3):352–361. doi:10.1016/S0168-8278(88)80008-4.
   PubMed Web of Science ®Google Scholar
• Alexandra F, Yukihiko S, Eri S, Takayuki M, Atsushi I, Gerhard PP. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNF alpha-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol. 2002;36(3):328–334. doi:10.1016/S0168-8278(01)00277-X.
   PubMed Web of Science ®Google Scholar
• Tang MR, Wang YX, Han SH, Shu G, Nan X, Guo JY. Endogenous PGE2 induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma. Oncol Lett. 2013;5(2):645–650. doi:10.3892/ol.2012.1047.
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhong J, Li DQ. EP4 antagonist alleviates symptoms of mice model of collagen induced arthritis by down regulating level of IL-17 and MCP-1. Chin J Joint Surg. 2015;9:618–622.
   Google Scholar
• Tan TG, Lim YS, Tan A, Leong R, Pavelka N. Fungal symbionts produce prostaglandin E-2 to promote their intestinal colonization. Front Cell Infect Mi. 2019;9:359. doi:10.3389/fcimb.2019.00359.
   PubMed Web of Science ®Google Scholar
• Alem MAS, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother. 2001;48(1):41–47. doi:10.1128/AAC.48.1.41-47.2004.
   Google Scholar
• Valdez PA, Vithayathil PJ, Janelsins BM, Shaffer AL, Williamson PR, Datta SK. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity. 2012;36(4):668–679. doi:10.1016/j.immuni.2012.02.013.
   PubMed Web of Science ®Google Scholar
• Smeekens SP, van de Veerdonk FL, van derMeer JW, Kullberg BJ, Joosten LA, Netea MG. The Candida Th17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2. Int Immunol. 2010;22:889–895. doi:10.1093/intimm/dxq442.
   PubMed Web of Science ®Google Scholar
• Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013;8(3):627–637. doi:10.1038/nprot.2013.032.
   PubMed Web of Science ®Google Scholar
• Wang K, Bao L, Zhou N, Zhang J, Liao M, Zheng Z, Wang Y, Liu C, Wang J, Wang L, et al. Structural modification of natural product Ganomycin I leading to discovery of a alpha-Glucosidase and HMG-CoA reductase dual inhibitor improving obesity and metabolic dysfunction in vivo. J Med Chem. 2018;61(8):3609–3625. doi:10.1021/acs.jmedchem.8b00107.
   PubMed Web of Science ®Google Scholar